Hepatic synthesis and secretion of apolipoprotein B (apo B) is metabolically regulated by dietary and hormonal factors. Recent evidence suggests that diet and hormones regulate a novel form of RNA processing known as mRNA editing. Edited apo B mRNA translates into a lower molecular weight protein (apo B -L) due to the conversion of a glutamine codon to an in-frame stop codon through a specific single base change of cytidine to uridine in codon 2153 (CAA->UAA). Macromolecular assemblies involved in mRNA editing (editosomes) have been recently identified in vitro and proposed to carry out the specific C->U conversion on riboprobes of apo B cDNA subclones. RNA editing and the 27S editosome have characteristic properties of recognition, assembly and catalysis seen with many other ribonucleoprotein-dependent processes. Immunological, molecular and biochemical techniques have been proposed for purifying editosomes, characterizing their macromolecular composition and determining the mechanism underlying RNA recognition and nucleotide conversion. Monoclonal antibodies specific for the editosome components will be produced and immunoassays developed for qualitative and quantitative analyses of structure and function. These studies will be complemented by molecular analysis of editing-specificity using mutant apo B mRNA constructs which focus on sequences flanking the editing site. Description of tissue-specific characteristics which might underlie the quantitative differences in editing activity seen in liver and intestine will also be evaluated. The significance of the proposed research lies in its potential to describe metabolic regulation of apo B production at the level of the mechanism of mRNA editing and the specific macromolecules whose synthesis and/or interactions participate in the control. The results of the proposed studies have implications regarding the hepatic production of LDL (unedited apo B) and intestinal production of chylomicrons (edited apo B) with respect to the variable atherogenic potential of these lipoprotein fractions in humans. Moreover, the information obtained in these studies will be important for evaluating the generic properties of mRNA editing and identifying other mRNAs which might serve as editing substrates.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK043739-01A1
Application #
3245201
Study Section
Metabolism Study Section (MET)
Project Start
1992-03-01
Project End
1995-02-28
Budget Start
1992-03-01
Budget End
1993-02-28
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Rochester
Department
Type
Schools of Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Polevoda, Bogdan; McDougall, William M; Bennett, Ryan P et al. (2016) Structural and functional assessment of APOBEC3G macromolecular complexes. Methods 107:10-22
Prohaska, Kimberly M; Bennett, Ryan P; Salter, Jason D et al. (2014) The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions. Wiley Interdiscip Rev RNA 5:493-508
Smith, Harold C; Bennett, Ryan P; Kizilyer, Ayse et al. (2012) Functions and regulation of the APOBEC family of proteins. Semin Cell Dev Biol 23:258-68
Galloway, Chad A; Smith, Harold C (2010) The expression of apoB mRNA editing factors is not the sole determinant for the induction of editing in differentiating Caco-2 cells. Biochem Biophys Res Commun 391:659-63
Galloway, Chad A; Ashton, John; Sparks, Janet D et al. (2010) Metabolic regulation of APOBEC-1 complementation factor trafficking in mouse models of obesity and its positive correlation with the expression of ApoB protein in hepatocytes. Biochim Biophys Acta 1802:976-85
Galloway, C A; Kumar, A; Krucinska, J et al. (2010) APOBEC-1 complementation factor (ACF) forms RNA-dependent multimers. Biochem Biophys Res Commun 398:38-43
Lehmann, David M; Galloway, Chad A; MacElrevey, Celeste et al. (2007) Functional characterization of APOBEC-1 complementation factor phosphorylation sites. Biochim Biophys Acta 1773:408-18
Smith, Harold C (2007) Measuring editing activity and identifying cytidine-to-uridine mRNA editing factors in cells and biochemical isolates. Methods Enzymol 424:389-416
Sparks, Janet D; Collins, Heidi L; Chirieac, Doru V et al. (2006) Hepatic very-low-density lipoprotein and apolipoprotein B production are increased following in vivo induction of betaine-homocysteine S-methyltransferase. Biochem J 395:363-71
Lehmann, David M; Galloway, Chad A; Sowden, Mark P et al. (2006) Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor. Nucleic Acids Res 34:3299-308

Showing the most recent 10 out of 46 publications